Serum CEA serves as a representative tumor marker and is known to be elevated in various solid tumors, including colorectal cancer, gastric cancer, pancreatic cancer, pulmonary cancer, breast cancer and head and neck cancer. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.